"As it was, the text could raise doubts about the taxation of imported medications by individuals," says the Minister of Institutional Relations

Free webinar will clarify Medicinal Cannabis Regulation in Brazil

Porto Alegre's Health Secretary holds a meeting with representatives of the agenda and defines next steps to distribute medications through the Unified Health System (SUS), Legislative Assembly awaits a report from a deputy to advance discussions on cannabis

Decree No. 4,977 published in the Official Gazette establishes guidelines for provision by the State Health agencies

Habeas Corpus is the only legal recourse for patients wishing to use the plant for the treatment of various diseases

Understand the step-by-step process to acquire plant derivatives for medicinal purposes

After participating in the Annual Convention of the European Industrial Hemp Association (EIHA) in Belgium and visiting companies in Europe, Lorenzo Rolim da Silva brings exclusive insights on the latest developments in the international hemp market

Four experts report on the various experiences of cultivating cannabis for medicinal and industrial purposes in Brazil and abroad, mapping best practices and the main difficulties for the development of the activity

Created by Danilo Lang, the platform is the first of its kind to offer jobs for the cannabis market in Brazil.

Sechat has developed a guide to help you file an HC in court

Patients whose data was exposed by the agency fear being targeted for advertising and retaliation

The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Studies published in the United States and the United Kingdom indicate that cannabis use may affect the brain differently in adulthood and aging

In an interview with the CB.Poder program of Correio Brasiliense, conducted by journalists Adriana Bernardes and Sibele Negromonte, Leandro Safatle, acting CEO of Anvisa, detailed the behind-the-scenes and expectations regarding the new regulation of medicinal cannabis and research in Brazil

Regulatory advances and scientific potential put the country on the radar of international investors and consolidate the veterinary sector

New research relies on rigorous methodologies, such as double-blind studies, and investigates the potential of lesser-known cannabinoids, such as CBG and THCV

President advances in the medicinal agenda and targets elderly electorate with CBD in Medicare, but signs law that threatens hemp market

Debate on the Sechat Portal podcast compares Rivotril and medical cannabis, highlighting effectiveness, safety, side effects, and differences between acute use and long-term treatment

Proposal creates a legal framework for production, importation, and self-cultivation; the report included strict security requirements for the medicinal use of cannabis

Amid the celebration of Brazilian cinema with "The Secret Agent," we gather national productions that help understand the trajectory of cannabis in the country